From: Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
 | No. | No. case | OR1 (95% CI) | OR2 (95% CI) |
---|---|---|---|---|
PRS for BC overall | ||||
 Q1 | 2952 | 46 | 1.00 (REF) | 1.00 (REF) |
 Q2 | 2952 | 46 | 1.05 (0.69–1.59) | 1.08 (0.71–1.64) |
 Q3 | 2964 | 34 | 0.93 (0.55–1.56) | 0.95 (0.56–1.60) |
 Q4 | 2937 | 60 | 1.90 (1.05–3.45) | 1.98 (1.09–3.60) |
P for trend | Â | Â | 0.07 | 0.06 |
 Standardized continuous |  |  | 1.19 (0.96–1.48) | 1.21 (0.97–1.50) |
PRS for ER + BC | ||||
 Q1 | 2953 | 44 | 1.00 (REF) | 1.00 (REF) |
 Q2 | 2948 | 50 | 1.19 (0.79–1.80) | 1.22 (0.81–1.85) |
 Q3 | 2965 | 33 | 0.91 (0.54–1.53) | 0.93 (0.55–1.57) |
 Q4 | 2939 | 59 | 1.83 (1.01–3.30) | 1.90 (1.04–3.43) |
P for trend | Â | Â | 0.09 | 0.07 |
 Standardized continuous |  |  | 1.18 (0.96–1.46) | 1.20 (0.97–1.48) |
PRS for ER − BC | ||||
 Q1 | 2952 | 45 | 1.00 (REF) | 1.00 (REF) |
 Q2 | 2958 | 41 | 0.92 (0.60–1.41) | 0.93 (0.61–1.43) |
 Q3 | 2947 | 51 | 1.16 (0.77–1.75) | 1.19 (0.79–1.80) |
 Q4 | 2948 | 49 | 1.12 (0.73–1.72) | 1.15 (0.75–1.77) |
P for trend | Â | Â | 0.41 | 0.33 |
 Standardized continuous |  |  | 1.07 (0.92–1.25) | 1.09 (0.93–1.27) |